Quantcast
Channel: Defeat Osteosarcoma » vaccination
Browsing latest articles
Browse All 6 View Live

ImmunoCellular (IMUC) to Present at the 16th Annual Meeting of the Society...

November 18, 2011 ImmunoCellular Therapeutics Ltd. (OTCBB: IMUC), a biopharmaceutical company developing new therapeutics to fight cancer using the immune system, is taking a different approach than...

View Article



A New Type of Dendritic Cell-Based Cancer Vaccine has Received Approval for...

press release Nov. 25, 2011, 6:57 a.m. EST GOTHENBURG, Sweden, November 25, 2011 /PRNewswire via COMTEX/ — Immunicum, which is developing cancer vaccines, has received approval from the Swedish...

View Article

activation of antitumor cytotoxic T lymphocytes by fusion of patient-derived...

Experimental Oncology 27, 273-278, 2005 (December) 273 Z. Yu*, B. Ma, Y. Zhou, M. Zhang, X. Qiu, Q. Fan Center of Orthopedic Surgery Orthopedics Oncology Institute of Chinese PLA, Tangdu Hospital,...

View Article

Using the body’s own immune system in the fight against cancer

February 8, 2012 DNA sequences from tumor cells can be used to direct the immune system to attack cancer, according to scientists at Washington University School of Medicine in St. Louis. The research,...

View Article

Researchers find sarcoma tumor immune response with combination therapy

March 1, 2012 in Cancer A team of 18 researchers at Moffitt Cancer Center in Tampa, Fla., have found that treating high-risk, soft tissue sarcoma patients with a combination of implanted dendritic...

View Article


Image may be NSFW.
Clik here to view.

Insight: New doubts about prostate-cancer vaccine Provenge

Fri, Mar 30 2012 By Sharon Begley NEW YORK (Reuters) – Prostate cancer vaccine Provenge has long incited passions unlike any other cancer therapy. Doctors who raised doubts about it received death...

View Article
Browsing latest articles
Browse All 6 View Live




Latest Images